Apixaban Impurity E | CAS 1609409-53-1 - Request Quote
Apixaban Impurity E
| SZ CAT No: | SZ-A062058 |
| CAS No | 1609409-53-1 |
| Mol.F. | C20H22N2O6 |
| Mol.Wt. | 386.4 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Apixaban Impurity E is chemically Ethyl{5-hydroxy-6-oxo-1-[4-(2-oxopiperidin-1-yl)phenyl]-1,2,3,6-tetrahydropyridin-4-yl}(oxo)acetate. Apixaban Impurity E is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity E can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1609409-53-1
Purchase 1609409-53-1
Order 1609409-53-1
Enquire 1609409-53-1
price of 1609409-53-1
1609409-53-1 Supplier
1609409-53-1 Manufacturer
1609409-53-1 Exporter
buy high quality Apixaban Impurity E
Purchase Apixaban Impurity E
Apixaban Impurity E suppliers
Apixaban Impurity E manufacturers
Apixaban Impurity E price
Order Apixaban Impurity E
Enquire Apixaban Impurity E
Apixaban Impurity E cost
Apixaban Impurity E Supplier
Apixaban Impurity E Distributor
Apixaban Impurity E for Method Validation
Apixaban Reference Standard
Apixaban Impurity E for ANDA Filing
Apixaban Impurity E for Forced Degradation Studies
Apixaban Impurity E Identification Standards
Apixaban Impurity E for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.